Copyright
©The Author(s) 2024.
World J Cardiol. Oct 26, 2024; 16(10): 574-579
Published online Oct 26, 2024. doi: 10.4330/wjc.v16.i10.574
Published online Oct 26, 2024. doi: 10.4330/wjc.v16.i10.574
Table 2 Outcomes of MANTA vascular closure device post venoarterial extracorporeal membrane oxygenation decannulation, n (%)
| Items | Overall (n = 19) |
| Survival to discharge | |
| Yes | 16 (84.2) |
| No | 3 (15.8) |
| Additional closure method | |
| None | 17 (89.5) |
| Manual pressure | 2 (10.5) |
| Bleeding | |
| No | 17 (89.5) |
| Yes | 2 (10.5) |
| Bleeding based on BARC | |
| No Bleeding | 17 (89.5) |
| Type 1 | 0 (0) |
| Type 2 | 1 (5.3) |
| Type 3 | 1 (5.3) |
| Type 4 | 0 (0) |
| Type 5 | 0 (0) |
| Limb Ischemia post MANTA | |
| No | 17 (89.5) |
| Yes | 2 (10.5) |
- Citation: Milioglou I, Qian A, Salerno PRVO, Pereira GTR, Palma Dallan LA, Gray KE, Morrison M, Abu-Omar Y, Eldiasty M, Baeza C. Percutaneous decannulation of extracorporeal membrane oxygenation using MANTA device: A real-world single-center experience. World J Cardiol 2024; 16(10): 574-579
- URL: https://www.wjgnet.com/1949-8462/full/v16/i10/574.htm
- DOI: https://dx.doi.org/10.4330/wjc.v16.i10.574